BIOMAT Database Logo BIOMAT Database Logo

Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. 1994

H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas.

Six procedures for quantifying plasma human immunodeficiency virus type 1 (HIV-1) RNA were evaluated by nine laboratories. The procedures differed in their sample volume and preparation of samples and methods of amplification and detection. Coded samples in a 10-fold dilution series of HIV-1-spiked plasma were correctly ranked by all six procedures. Subsequently, coded duplicate plasma samples from 16 HIV-1-infected patients were tested using a common set of standards. Several HIV-1 RNA procedures were sufficiently reproducible so that an empiric 4-fold change could be viewed as significant. HIV-1 RNA levels in the patients (up to 370,000 RNA copies/mL) correlated with proviral HIV-1 DNA and were inversely correlated with CD4 cell counts; HIV-1 RNA assays were more sensitive than plasma viremia, standard p24 antigen, or immune complex-dissociated p24 antigen assays. This study demonstrated that several HIV-1 RNA quantitative assays are ready for use in clinical trials.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014766 Viremia The presence of viruses in the blood. Viremias

Related Publications

H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
December 1996, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma.
June 2000, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.
July 1998, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
May 1996, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Affordable, abbreviated roche monitor assay for quantification of human immunodeficiency virus type 1 RNA in plasma.
August 2005, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA.
January 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
[Evaluation of a PCR assay commercial kit for quantification of human immunodeficiency virus type-1 RNA].
October 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.
December 1996, Journal of clinical microbiology,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.
April 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
H J Lin, and L E Myers, and B Yen-Lieberman, and F B Hollinger, and D Henrard, and C J Hooper, and R Kokka, and S Kwok, and S Rasheed, and M Vahey
Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper.
November 1997, Journal of clinical microbiology,
Copied contents to your clipboard!